Klinische Studie

Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)

NCT: NCT05557123 · COMPLETED

NCT-IDNCT05557123

Medizinische Daten: StatusCOMPLETED

Startdatum2022-03-10

Abschluss2025-12-16

SponsorSeoul National University Bundang Hospital (OTHER)

First posted2022-09-27

Last updated2026-05-19

Kurzzusammenfassung

RIVOX-AF study is a prospective, multicenter, randomized controlled study in which patients with AF are allocated to medication-app group or conventional treatment group. The App based feed-back algorithm will provide the patients with check taking drug or reminding of taking drug.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.